Capital Wealth Planning’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,607
Closed -$328K 145
2024
Q4
$328K Buy
3,607
+1,612
+81% +$154K ﹤0.01% 114
2024
Q3
$207K Buy
+1,995
New +$203K ﹤0.01% 132
2015
Q2
Sell
-12,000
Closed -$832K 124
2015
Q1
$832K Sell
12,000
-11,995
-50% -$829K 0.43% 52
2014
Q4
$1.66M Buy
23,995
+3,020
+14% +$204K 0.77% 25
2014
Q3
$1.37M Hold
20,975
0.55% 36
2014
Q2
$1.43M Hold
20,975
0.53% 38
2014
Q1
$1.36M Buy
+20,975
New +$1.32M 0.59% 35
2013
Q4
Sell
-13,685
Closed -$811K 76
2013
Q3
$811K Buy
+13,685
New +$811K 0.37% 46

Other funds holding CL

Capital Wealth Planning's CL Position: Q1 2025 in Review

Capital Wealth Planning sold out of Colgate-Palmolive (CL) in Q1 2025, closing a stake of 3,607 shares — an estimated $328K sold.

Capital Wealth Planning first reported a position in CL in Q3 2013 and held it in 8 quarters. The position peaked at $1.66M in Q4 2014. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2025.

  • Capital Wealth Planning reported no remaining Colgate-Palmolive position as of Q1 2025 after selling out during the quarter.
  • Capital Wealth Planning sold 3,607 Colgate-Palmolive shares in Q1 2025, an estimated $328K.
  • Capital Wealth Planning first reported a position in Colgate-Palmolive in Q3 2013 and held it in 8 quarters.
  • Capital Wealth Planning's Colgate-Palmolive position peaked at $1.66M in Q4 2014.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Capital Wealth Planning's 13F filing for Q1 2025, filed 12 May 2025.